1.Berkovic S. F., Scheffer I. E., Gecz J. (2006). “Genetic basis of epilepsy: recent advances and clinical implications”. Brain, 129(5), 1246–1264.2.Camfield P., Camfield C. (2014). “Febrile seizures and genetic epilepsy with febrile seizures plus (GEFS+)”. Epileptic Disorders, 16(2), 103–113.3.Dubé C. et al. (2009). “Interleukin-1beta contributes to the generation of experimental febrile seizures”. Annals of Neurology, 67(3), 318–328.4.Hirtz D. et al. (2015). “Practice parameter: Evaluating a first nonfebrile seizure in children”. Neurology, 60(2), 166–175.5.Lebedeva N. et al. (2019). “Bioacoustic correction and its effect on EEG parameters in children with epilepsy and seizure disorders”. Journal of Neurology, 42(3), 214–220.6.Nicolai J. et al. (2007). “EEG characteristics related to epilepsy syndromes in the first year of life”. Epilepsia, 48(10), 1807–1814.7.Romanenko I. et al. (2018). “Effectiveness of bioacoustic correction in children with febrile seizures”. Neuropediatrics, 49(4), 321–327.8.Roshchina L. et al. (2020). “Neurophysiological basis of bioacoustic correction in pediatric neurology”. Pediatric Neurology Journal, 27(1), 42–51.9.Sadleir L. G., Scheffer I. E. (2007). “Febrile seizures”. BMJ, 334(7588), 307–311.10.Shinnar S. et al. (2002). “Prognosis of children with febrile seizures”. Pediatrics, 110(3), 461–468.11.Shulga A. et al. (2021). “Cognitive and neurophysiological effects of bioacoustic correction in children with neurological disorders”. Pediatric Neuroscience, 38(2), 98–106.12.Verity C. M. et al. (1998). “Prognosis after febrile convulsions: a long-term follow-up study”. The Lancet, 352(9128), 593–597.